https://www.sppirx.com/
Freeline Completes 1-For-15 ADS Ratio Change
Freeline Therapeutics Holdings plc (NASDAQ:FRLN) today announced that the company's previously disclosed change to its American Depositary Share ("ADS") to ordinary share ratio has been made
